Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Taylor, Keryn L ^a   Hadgkiss, Emily J ^a   Jelinek, George A ^a,b   Weiland, Tracey J ^a   Pereira, Naresh G ^c   Marck, Claudia H ^a   van der Meer, Dania M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

Depression; Lifestyle; Multiple sclerosis; Survey

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; FISH OIL; INTERFERON BETA SERINE; LINSEED OIL; OMEGA 3 FATTY ACID; VITAMIN D; VITAMIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DIET SUPPLEMENTATION; EXERCISE; EXPANDED DISABILITY STATUS SCALE; FATIGUE SEVERITY SCALE; FEMALE; FISH; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NUTRITIONAL ASSESSMENT; OBESITY; PATIENT HEALTH QUESTIONNAIRE 2; RISK ASSESSMENT; SMOKING; SOCIAL ISOLATION; SOCIAL SUPPORT; VITAMIN SUPPLEMENTATION; DEPRESSIVE DISORDER; DISABLED PERSON; EDUCATIONAL STATUS; EMPLOYMENT; MARRIAGE; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DIETARY SUPPLEMENTS; DISABLED PERSONS; EDUCATIONAL STATUS; EMPLOYMENT; EXERCISE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LIFE STYLE; MALE; MARITAL STATUS; MIDDLE AGED; MULTIPLE SCLEROSIS; OBESITY; QUALITY OF LIFE; RISK FACTORS; SMOKING; SOCIAL SUPPORT; SURVEYS AND QUESTIONNAIRES; VITAMIN D; VITAMINS;

EID: 84924103165     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0327-3     Document Type: Article

References (76)

1. D'Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A: Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil 2006, 28(5):307-314.
2. Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G, Amore M, Girardi P: Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res 2012, 73(6):411-417.
3. Khan F, McPhail T, Brand C, Turner-Stokes L, Kilpatrick T: Multiple sclerosis: disability profile and quality of life in an Australian community cohort. Int J Rehabil Res 2006, 29(2):87-96.
4. Jose Sa M: Psychological aspects of multiple sclerosis. Clin Neurol Neurosurg 2008, 110(9):868-877.
5. Kanner AM, Barry JJ: The impact of mood disorders in neurological diseases: should neurologists be concerned? Epilepsy Behav 2003, 4(Suppl 3):S3-S13.
6. Ytterberg C, Lundqvist S, Johansson S: Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study. BMC Health Serv Res 2013, 13:365.
7. Minden SL, Ding L, Cleary PD, Frankel D, Glanz BI, Healy BC, Rintell DJ: Improving the quality of mental health care in multiple sclerosis. J Neurol Sci 2013, 335(1-2):42-47.
8. Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J: Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev 2011, 2:CD007295.
9. Fragoso YD, Adoni T, Anacleto A, Da Gama PD, Goncalves MV, Matta AP, Parolin MF: Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. Pract Neurol 2014, 14(4):206-209.
10. Sarris J, O'Neil A, Coulson CE, Schweitzer I, Berk M: Lifestyle medicine for depression. BMC Psychiatry 2014, 14(1):107.
11. García-Toro M, Ibarra O, Gili M, Serrano MJ, Oliván B, Vicens E, Roca M: Four hygienic-dietary recommendations as add-on treatment in depression: a randomized-controlled trial. J Affect Disord 2012, 140(2):200-203.
12. Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, Steiner C: MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 2010, 75(13):1141-1149.
13. Jacka FN, Mykletun A, Berk M: Moving towards a population health approach to the primary prevention of common mental disorders. BMC Med 2012, 10:149.
14. Jensen MP, Smith AE, Bombardier CH, Yorkston KM, Miro J, Molton IR: Social support, depression, and physical disability: age and diagnostic group effects. Disabil Health J 2014, 7(2):164-172.
15. Vargas GA, Arnett PA: Positive everyday experiences interact with social support to predict depression in multiple sclerosis. J Int Neuropsychol Soc 2010, 16(6):1039-1046.
16. Stuifbergen AK, Becker H: Health promotion practices in women with multiple sclerosis: increasing quality and years of healthy life. Physical Med Rehabil Clin North Am 2001, 12(1):9-22.
17. Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, Van Der Meer DM: Methodology of an international study of people with multiple sclerosis recruited through Web 2.0 platforms: demographics, lifestyle, and disease characteristics. Neurol Res Int 2013, 2013:580596.
18. Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, Van Der Meer DM: The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci 2014:1-13
19. Weiland TJ, Hadgkiss EJ, Jelinek GA, Pereira NG, Marck CH, van der Meer DM: The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014, 336(1-2):211-219.
20. Jelinek GA, Hadgkiss EJ, Weiland TJ, Pereira NG, Marck CH, Van Der Meer DM: Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci 2013, 123(11):792-800.
21. Global Database Of Body Mass Index. BMI Classification [ http://apps.who.int/bmi/index.jsp?introPage=intro_3.html ]
22. Sjonnesen K, Berzins S, Fiest KM AGMB, Metz LM, Thombs BD, Patten SB: Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis. Postgrad Med 2012, 124(5):69-77.
23. Kroenke K, Spitzer RL, Williams JB: The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003, 41(11):1284-1292.
24. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10):1121-1123.
25. Lerdal A, Celius EG, Moum T: Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult Scler 2003, 9(5):509-514.
26. Smedal T, Beiske AG, Glad SB, Myhr KM, Aarseth JH, Svensson E, Gjelsvik B, Strand LI: Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance. Eur J Neurol 2011, 18(1):114-120.
27. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T: Validation of the NARCOMS registry: fatigue assessment. Mult Scler 2005, 11(5):583-584.
28. Hohol MJ, Orav EJ, Weiner HL: Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology 1995, 45(2):251-255.
29. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T: Changes in the ascertainment of multiple sclerosis. Neurology 2005, 65(7):1066-1070.
30. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D: Does multiple sclerosis-associated disability differ between races? Neurology 2006, 66(8):1235-1240.
31. Hadjimichael O, Vollmer T, Oleen-Burkey M, North American Research Committee on Multiple Sclerosis: Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Q Life Outcomes 2008, 6:100.
32. Holper L, Coenen M, Weise A, Stucki G, Cieza A, Kesselring J: Characterization of functioning in multiple sclerosis using the ICF. J Neurol 2010, 257(1):103-113.
33. McKellar S, Horsley P, Chambers R, Pullen M, Vendersee P, Clarke C, Callum H, Bauer J: Development of the diet habits questionnaire for use in cardiac rehabilitation. Aust Primary Health 2008, 14(3):43-47.
34. Fragoso YD, Frota ER, Lopes JS, Noal JS, Giacomo MC, Gomes S, Goncalves MV, da Gama PD, Finkelsztejn A: Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clin Neuropharmacol 2010, 33(6):312-316.
35. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35(8):1381-1395.
36. Weikert M, Motl RW, Suh Y, McAuley E, Wynn D: Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility? J Neurol Sci 2010, 290(1-2):6-11.
37. Reavley N, Pallant JF, Sali A: Evaluation of the effects of a psychosocial intervention on mood, coping, and quality of life in cancer patients. Integr Cancer Ther 2009, 8(1):47-55.
38. Koopman C, Nouriani B, Erickson V, Anupindi R, Butler LD, Bachmann MH, Sephton SE, Spiegel D: Sleep disturbances in women with metastatic breast cancer. Breast J 2002, 8(6):362-370.
39. Induruwa I, Constantinescu CS, Gran B: Fatigue in multiple sclerosis - a brief review. J Neurol Sci 2012, 323(1-2):9-15.
40. Lebrun C, Cohen M: [Depression in multiple sclerosis]. Rev Neurol 2009, 165(Suppl 4):S156-S162.
41. Holden K, Isaac CL: Depression in multiple sclerosis: reactive or endogenous? Clin Neuropsychol 2011, 25(4):624-639.
42. Heesen C, Kopke S, Kasper J, Poettgen J, Tallner A, Mohr DC, Gold SM: Behavioral interventions in multiple sclerosis: a biopsychosocial perspective. Expert Rev 2012, 12(9):1089-1100.
43. Vattakatuchery JJ, Rickards H, Cavanna AE: Pathogenic mechanisms of depression in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2011, 23(3):261-276.
44. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW: Depression and multiple sclerosis. Neurology 1996, 46(3):628-632.
45. D'Hooghe MB, De Keyser J: Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis. Expert Rev Neurother 2012, 12(6):657-660.
46. Moore P, Hirst C, Harding KE, Clarkson H, Pickersgill TP, Robertson NP: Multiple sclerosis relapses and depression. J Psychosom Res 2012, 73(4):272-276.
47. Feinstein A: Mood disorders in multiple sclerosis and the effects on cognition. J Neurol Sci 2006, 245(1-2):63-66.
48. Gold SM, Irwin MR: Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Immunol Allergy Clin North Am 2009, 29(2):309-320.
49. Pokryszko-Dragan A, Frydecka I, Kosmaczewska A, Ciszak L, Bilinska M, Gruszka E, Podemski R, Frydecka D: Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis. Clin Neurol Neurosurg 2012, 114(8):1153-1158.
50. Csiszar A, Podlutsky A, Wolin MS, Losonczy G, Pacher P, Ungvari Z: Oxidative stress and accelerated vascular aging: implications for cigarette smoking. Front Biosci (Landmark Ed) 2009, 14:3128-3144.
51. Golzari Z, Shabkhiz F, Soudi S, Kordi MR, Hashemi SM: Combined exercise training reduces IFN-gamma and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis. Int Immunopharmacol 2010, 10(11):1415-1419.
52. Levin AB, Hadgkiss EJ, Weiland TJ, Jelinek GA: Meditation as an adjunct to the management of multiple sclerosis. Neurol Res Int 2014, 2014:704691.
53. Saunders C, Caon C, Smrtka J, Shoemaker J: Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis. J Neurosci Nurs 2010, 42(55):10-18.
54. Ensari I, Motl RW, McAuley E, Mullen SP, Feinstein A: Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis. Mult Scler 2014, 20(5):602-609.
55. Hadgkiss EJ, Jelinek GA, Weiland TJ, Rumbold G, Mackinlay CA, Gutbrod S, Gawler I: Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis. Neurol Sci 2013, 34(2):187-195.
56. Li MP, Jelinek GA, Weiland TJ, Mackinlay CA, Dye S, Gawler I: Effect of a residential retreat promoting lifestyle modifications on health-related quality of life in people with multiple sclerosis. Q Primary Care 2010, 18(6):379-389.
57. Rahe C, Unrath M, Berger K: Dietary patterns and the risk of depression in adults: a systematic review of observational studies. Eur J Nutr 2014, 53(4):997-1013.
58. Sanhueza C, Ryan L, Foxcroft DR: Diet and the risk of unipolar depression in adults: systematic review of cohort studies. J Human Nutri Diet Off J British Dietetic Assoc 2013, 26(1):56-70.
59. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A: Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr 2013, 13(1):1-14.
60. Park S, Romer D, Lim S: Does smoking initiation in adolescence increase risk for depression across the lifespan? Evidence from the South korean national health and nutrition examination survey. J Addict Nurs 2013, 24(3):142-148.
61. Heikkinen H, Jallinoja P, Saarni SI, Patja K: The impact of smoking on health-related and overall quality of life: a general population survey in Finland. Nicotine Tob Res Off J Soc Res Nicotine Tob 2008, 10(7):1199-1207.
62. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML: Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Therapeutics 2000, 293(1):166-171.
63. Edwards AC, Kendler KS: A twin study of depression and nicotine dependence: shared liability or causal relationship? J Affect Disord 2012, 142(1-3):90-97.
64. Goretti B, Portaccio E, Zipoli V, Hakiki B, Siracusa G, Sorbi S, Amato MP: Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 2009, 30(1):15-20.
65. Stroud NM, Minahan CL: The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Q Life Outcomes 2009, 7:68.
66. Hibbeln JR, Salem N Jr: Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62(1):1-9.
67. Simopoulos AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002, 21(6):495-505.
68. Khoraminya N, Tehrani-Doost M, Jazayeri S, Hosseini A, Djazayery A: Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust New Zealand J Psychiatry 2013, 47(3):271-275.
69. Ashtari F, Ajalli M, Shaygannejad V, Akbari M, Hovsepian S: The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis. J Res Med Sci Off J Isfahan Univ Med Sci 2013, 18(3):193-197.
70. Brum DG, Comini-Frota ER, Vasconcelos CC, Dias-Tosta E: Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology. Arq Neuropsiquiatr 2014, 72(2):152-156.
71. Shelton RC, Miller AH: Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 2010, 91(4):275-299.
72. Lopresti AL, Drummond PD: Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 2013, 45:92-99.
73. Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, Berger Z, Sleicher D, Maron DD, Shihab HM, Ranasinghe PD, Linn S, Saha S, Bass EB, Haythornthwaite JA: Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Inter Med 2014, 174(3):357-368.
74. Tavee J, Stone L: Healing the mind: meditation and multiple sclerosis. Neurology 2010, 75(13):1130-1131.
75. Ngo TL: Review of the effects of mindfulness meditation on mental and physical health and its mechanisms of action. Sante Mentale au Quebec 2013, 38(2):19-34.
76. Fragoso YD: Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. Pract Neurol 2014, 14(4):206-209.